SCHEMBL6468971

SCHEMBL6468971

COc1cc(OC)c2nc([NH])nc(C)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
RAD52 P43351 1/20 0.44
MEN1 O00255 3/20 0.43
CYP1A2 P05177 3/20 0.43
CYP3A4 P08684 2/20 0.43
GAA P10253 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C19 P33261 2/20 0.43
JAK2 O60674 1/20 0.43
KDM4E B2RXH2 4/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
JUND P17535 1/20 0.38
FOSB P53539 1/20 0.38
PDE10A Q9Y233 8/20 0.38
PDE4D Q08499 2/20 0.38
NQO2 P16083 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12135957 0.80 KMT2A (0.47) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL20813807 0.74 PDE5A (0.42) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL20867656 0.72 MAPT (0.50) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL2124865 0.72 KMT2A (0.49) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL2125303 0.72 CYP3A4 (0.49) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL22750299 0.70 CRHR1 (0.47) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL20521814 0.70 CYP3A4 (0.44) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL22196185 0.70 KMT2A (0.44) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL20521940 0.70 KMT2A (0.44) KMT2ASMN1; SMN2LMNAPOLBRAD52
SCHEMBL29923906 0.70 CRHR1 (0.47) KMT2ASMN1; SMN2LMNAPOLBRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed